Business
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Receipt of Approval from Health Canada for Two of the Company's Barium Contrast Products - Video Available on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - February 17, 2021) - Voyageur Pharmaceuticals (...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Receipt of Approval from Health Canada for Two of the Company's Barium Contrast Products - Video Available on Investmentpitch.comVancouver, British Columbia--(Newsfile Corp. - February 17, 2021) - Voyageur Pharmaceuticals (TSXV: VM) (OTCQB: VYYRF) has received approval from Health Canada for two of the company's barium contrast products.SmoothX, the company's barium radiographic contrast suspension specifically formulated for computed tomography procedures, commonly known as CT Scans, along with HDX Ba, a barium radiographic contrast powder specifically formulated for Fluoroscopy barium X-Ray procedures that can also be used for CT Scans, have both received Health Canada's approval. Contrast materials, which may be taken orally or rectally, are used to improve pictures of the inside of the body helping to distinguish or \"contrast\" selected areas of the body from surrounding tissue allowing the radiologist to distinguish normal from abnormal conditions.For more information, please view the InvestmentPitch Media \"video\" which provides additional information about this news and the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter \"Voyageur\" in the search box.Cannot view this video? Visit:http://www.investmentpitch.com/video/1_w9tq0di9/Voyageur-Pharmaceuticals-receives-Health-Canada-approval-for-two-barium-contrast-productsWith these Health Canada approvals, Voyageur is authorized to provide both SmoothX and HDX Ba for use in radiology procedures in Canada. SmoothX is specifically designed for use on CT Scans of the abdomen and gastrointestinal tract whereas HDX Ba is specifically designed for X-Ray procedures of the entire upper and lower gastrointestinal tract, including the stomach and duodenum, with both products used for both adults and pediatric patients. The company has three additional barium radiographic contrast products currently under review by Health Canada with management expecting product licences to be forthcoming.Brent Willis, President and CEO, stated: \"Voyageur's business plan has always been to launch Barium Contrast Radiographic Suspension products into the Canadian marketplace initially, then pursue other markets. This approval is the critical milestone to allow our company to transition to a cash flowing ...